Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aged 18 Years and Older”

214 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 214 results

Large-scale testing (Phase 3)Study completedNCT05572879
What this trial is testing

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

Who this might be right for
COVID-19
EuBiologics Co.,Ltd 2,600
Large-scale testing (Phase 3)Study completedNCT04526990
What this trial is testing

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Who this might be right for
COVID-19
CanSino Biologics Inc. 44,247
Large-scale testing (Phase 3)Ended earlyNCT05643573
What this trial is testing

Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke

Who this might be right for
Prevention of Stroke or Systemic EmbolismAtrial Fibrillation
Bayer 14,830
Testing effectiveness (Phase 2)Study completedNCT05373472
What this trial is testing

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

Who this might be right for
COVID-19
CanSino Biologics Inc. 150
Testing effectiveness (Phase 2)UnknownNCT05522829
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 400
Large-scale testing (Phase 3)Study completedNCT03379727
What this trial is testing

Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 301
Large-scale testing (Phase 3)Study completedNCT03760146
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults

Who this might be right for
Pneumococcal Disease
Pfizer 3,902
Testing effectiveness (Phase 2)Looking for participantsNCT07379580
What this trial is testing

Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

Who this might be right for
Mpox (Monkeypox)SmallpoxOrthopoxvirus Infection
BioNTech SE 310
Testing effectiveness (Phase 2)Study completedNCT00792623
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).

Who this might be right for
Varicella
GlaxoSmithKline 45
Post-approval studies (Phase 4)Study completedNCT04911790
What this trial is testing

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 131,650
Testing effectiveness (Phase 2)Study completedNCT05525208
What this trial is testing

Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

Who this might be right for
COVID-19
PT Bio Farma 696
Testing effectiveness (Phase 2)Study completedNCT06015308
What this trial is testing

Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo

Who this might be right for
Dermatitis Atopic
Sanofi 224
Very early researchUnknownNCT05679466
What this trial is testing

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Who this might be right for
Prevention of COVID-19 Caused by SARS-CoV-2
Yu Qin 3,300
Early research (Phase 1)Study completedNCT04552366
What this trial is testing

A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults

Who this might be right for
COVID-19
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China 149
Large-scale testing (Phase 3)UnknownNCT04847102
What this trial is testing

A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above

Who this might be right for
COVID-19SARS-CoV-2
Walvax Biotechnology Co., Ltd. 28,000
Early research (Phase 1)Study completedNCT02000700
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05523167
What this trial is testing

Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Who this might be right for
Active Idiopathic Inflammatory MyopathyMyositisDermatomyositis+3 more
argenx 265
Large-scale testing (Phase 3)Ended earlyNCT05683600
What this trial is testing

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 3,000
Large-scale testing (Phase 3)Study completedNCT01884519
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older

Who this might be right for
Influenza
GlaxoSmithKline 120
Large-scale testing (Phase 3)UnknownNCT05428592
What this trial is testing

Clinical Trial of SARS-CoV-2 mRNA Vaccine(LVRNA009) as Heterologous Booster in Islamabad

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 1,100
Load More Results